Education
About Us
Working with TipRanks
Follow Us
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
Technical Sentiment
Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Barinthus Biotherapeutics is a Sell.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 0.73, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 0.78, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics (BRNS) Pivot Points
Classic
0.70
0.71
0.72
0.73
0.75
0.76
0.78
Fibonacci
0.71
0.72
0.72
0.73
0.74
0.75
0.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Barinthus Biotherapeutics (BRNS) Moving Averages
MA5
0.72Sell
0.72Sell
MA10
0.73Sell
0.72Sell
MA20
0.73Sell
0.73Sell
MA50
0.72Sell
0.78Sell
MA100
0.96Sell
0.88Sell
MA200
1.03Sell
0.94Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 0.72, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 0.88, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 0.72, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 0.96, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 1.03, creating a Sell signal.
Barinthus Biotherapeutics (BRNS) Technical Indicators
RSI (14)
42.43
Neutral
STOCH (9,6)
44.44
Neutral
STOCHRSI (14)
35.80
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
8.64
Buy
Williams %R
-100.00
Buy
CCI (14)
-141.66
Buy
ATR (14)
0.04
-
Ultimate Oscillator
50.09
Neutral
ROC
-6.67
Sell
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 42.43, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 8.64, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is -141.66, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is -6.67, creating a Sell signal.
FAQ
Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Strong Sell.
What is BRNS’s RSI (14)?
BRNS’s RSI (14) is 42.43, which suggests BRNS is a Neutral.
What is BRNS’s MACD?
BRNS’s MACD is >-0.01, which suggests BRNS is a Sell.
What is BRNS’s 5-day moving average?
BRNS’s 5-day moving average is 0.72, which suggests BRNS is a Sell.
What is BRNS’s 20-day moving average?
BRNS 20-day moving average is 0.73, which suggests BRNS is a Sell.
What is BRNS’s 50-day moving average?
BRNS’s 50-day moving average is 0.72, which suggests BRNS is a Sell.
What is BRNS’s 200-day moving average?
BRNS’s 200-day moving average is 1.03, which suggests BRNS is a Sell.
What is BRNS’s Williams % R (14)?
BRNS’s Williams % R (14) is -100.00, which suggests BRNS is a Buy.
What is BRNS’s CCI (14)?
BRNS’s CCI (14) is -141.66, which suggests BRNS is a Buy.